Epizyme, Inc.
INHIBITORS OF EZH2 AND METHODS OF USE THEREOF

Last updated:

Abstract:

The disclosure provides a method of treating cancer in a subject in need thereof including administering to the subject a therapeutically-effective amount of an enhancer of a zeste homolog 2 (EZH2) inhibitor. In certain embodiments of this method, the subject has one or more mutations in one or more sequences encoding a gene listed in Tables 1-9, Tables 17-19, and/or FIGS. 19-22.

Status:
Application
Type:

Utility

Filling date:

9 Dec 2021

Issue date:

23 Jun 2022